Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Filana Therapeutics Inc., 2 years.
Filana Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Filana Therapeutics Inc. June 11, 202687.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 14, 2026 | PTC Therapeutics Inc. | Open-market sale | −3,494 | $80.35 | $280,743 |
| Feb 18, 2026 | PTC Therapeutics Inc. | Open-market sale | −2,992 | $69.36 | $207,525 |
| Jan 6, 2026 | PTC Therapeutics Inc. | Open-market sale | −2,139 | $76.95 | $164,596 |
| Jan 2, 2026 | PTC Therapeutics Inc. | Grant or award | +20,000 | — | — |
| Jul 15, 2025 | PTC Therapeutics Inc. | Open-market sale | −2,516 | $49.46 | $124,441 |
| Feb 20, 2025 | PTC Therapeutics Inc. | Open-market sale | −1,167 | $50.12 | $58,490 |
| Feb 19, 2025 | PTC Therapeutics Inc. | Open-market sale | −1,168 | $50.10 | $58,517 |
| Jan 3, 2025 | PTC Therapeutics Inc. | Grant or award | +22,500 | — | — |
| Jul 16, 2024 | PTC Therapeutics Inc. | Open-market sale | −2,269 | $34.02 | $77,191 |
| Feb 15, 2024 | PTC Therapeutics Inc. | Grant or award | +19,000 | — | — |
| Feb 15, 2024 | PTC Therapeutics Inc. | Grant or award | +3,100 | — | — |
| Dec 12, 2023 | PTC Therapeutics Inc. | Open-market purchase | +7,700 | $25.81 | $198,737 |
Questions about Pierre Gravier
What boards is Pierre Gravier on?
Pierre Gravier sits on the board of Filana Therapeutics Inc.
How long has Pierre Gravier served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.